MTOR and breast cancer: One study demonstrated that BITC treatment upregulates miR-99a-5p expression in the BC cell lines 5637 and T24 [76], which leads to decreased mRNA and protein levels of IGF-1R, FGF-R3, and mTOR in both BC cell lines.